Skip to Content

Concentration of Ixekizumab Paving the Way Towards Personalized Therapy in Psoriasis

Lisa Schots attended EADV 2023, where she talked about the role of Ixekizumab concentrations in optimizing its use in the treatment of psoriasis. The research indicates that patients with higher Ixekizumab concentrations in their blood had better clinical responses, which paves the way for more personalized treatments.

Lisa Schots

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top